LRRC16A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.018850E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.048800E-01
Normal-vs-Stage2
8.088000E-02
Normal-vs-Stage3
5.042200E-01
Normal-vs-Stage4
1.554260E-02
Stage1-vs-Stage2
6.939800E-01
Stage1-vs-Stage3
6.212800E-01
Stage1-vs-Stage4
3.380600E-01
Stage2-vs-Stage3
3.176200E-01
Stage2-vs-Stage4
4.387600E-01
Stage3-vs-Stage4
2.026200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.102550E-01
Normal-vs-AfricanAmerican
5.677700E-02
Normal-vs-Asian
2.382800E-01
Caucasian-vs-AfricanAmerican
4.054600E-01
Caucasian-vs-Asian
7.804800E-01
AfricanAmerican-vs-Asian
4.298200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.084420E-01
Normal-vs-Female
9.792300E-02
Male-vs-Female
2.913800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.400800E-01
Normal-vs-Age(41-60Yrs)
5.878500E-02
Normal-vs-Age(61-80Yrs)
1.293180E-01
Normal-vs-Age(81-100Yrs)
1.238770E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.397600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.457600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.758600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.882800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.449200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.968200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.348960E-01
Normal-vs-Daily Drinker
1.985630E-01
Normal-vs-Weekly Drinker
2.511200E-01
Normal-vs-Occasional Drinker
5.266200E-02
Normal-vs-Social Drinker
9.786300E-02
Non Drinker-vs-Daily Drinker
5.916400E-02
Non Drinker-vs-Weekly Drinker
7.916200E-01
Non Drinker-vs-Occasional Drinker
7.897600E-01
Non Drinker-vs-Social Drinker
9.253400E-01
Daily Drinker-vs-Weekly Drinker
3.122400E-01
Daily Drinker-vs-Occasional Drinker
2.530200E-02
Daily Drinker-vs-Social Drinker
6.383800E-02
Weekly Drinker-vs-Occasional Drinker
6.321200E-01
Weekly Drinker-vs-Social Drinker
7.540800E-01
Occasional Drinker-vs-Social Drinker
8.764800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.143240E-01
Normal-vs-Grade 2
1.563880E-02
Normal-vs-Grade 3
1.503820E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.721800E-02
Grade 1-vs-Grade 3
3.646400E-02
Grade 1-vs-Grade 4
1.143240E-01
Grade 2-vs-Grade 3
9.316000E-01
Grade 2-vs-Grade 4
1.563880E-02
Grade 3-vs-Grade 4
1.503820E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.069400E-01
Normal-vs-NonDiabetic
9.246200E-02
Diabetic-vs-NonDiabetic
6.582400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.549230E-01
Normal-vs-NoPancreatitis
1.242370E-01
Pancreatitis-vs-NoPancreatitis
4.104800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.420380E-01
Normal-vs-N1
7.573600E-02
N0-vs-N1
6.397400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.931910E-02
Normal-vs-TP53-NonMutant
1.185450E-01
TP53-Mutant-vs-TP53-NonMutant
3.633200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
